Open original FDA record ↗Recall record
- FDA identifier
- Z-3036-2020
- Company in FDA record
- Ameditech Inc
- FDA record creation date
- Sep 30, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Various immunoassay enzymes failed product performance, thereby the products do not consistently detect all calibrator and secondary compounds at the levels stated in the labeling.
Source facts
- Action
- A Field Corrective Action Notice letter was sent to affected consignees. The Customer notifications commenced on 19-Aug-2020. The consignees are requested to return all non-expired product in their possession to the recalling firm. Method of Notification, 1st contact: Written field corrective action notification letters will be sent via certified mail with delivery tracking to each consignee along with a pre-paid return label to return any product remaining in stock. 2nd & 3rd contact: Telephone, follow up email, or written mail communication will be used as necessary.
- Initiated
- 2020-08-18
- Root cause
- Process control
- Terminated
- 2024-09-30
- Distribution
- US - Nationwide OUS - Australia, France, Germany, New Zealand, Singapore and Spain
- Recall number
- Z-3036-2020
- Recall status
- Terminated
- CDRH record ID
- 183386
- FDA record created
- 2020-09-30
- Recall event number
- 86335